其它别名2,3,4-Tri-O-Benzyl-5-O-Prop-2-En-1-Yl-D-Ribitol; (2S,3S,4R)-5-(Allyloxy)-2,3,4-Tris(Benzyloxy)Pentan-1-Ol; (2S,3S,4R)-5-Allyloxy-3-Benzyloxy-2,4-Bis-((E)-2-; (2S,3S,4R)-2,3,4-Tris(Phenylmethoxy)-5-Prop-2-Enoxypentan-1-Ol; A
专利号:US-6765091-B1 优先权日:1999-08-30 标题:Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them 发明人:BENCOMO VICENTE GUILLERMO VERE; ROY RENE 权利人:UNIV LA HABANA; UNIV OTTAWA 摘要:The present invention relates to the field of the Medicine, in particular with the chemical synthesis of oligosaccharide mixtures derived of ribose-ribitol-phosphate, which are used as active principle in vaccines for the prevention of infections caused by Haemophilus influenzae type b (Hib), as well as with the vaccines containing said oligosaccharide mixtures. n The oligasaccharide mixtures obtained by chemical synthesis of the present invention, comprise repeating units of formulae (phosphate-ribosa-ribitol)n or (ribose-ribitol-phosphate)n of at least 5 compounds of structure A or B, which represent the repeating unit of the capsular polysaccharide of Haemophilus influenzae type b and differ only by n, being n a value contained between 4 and 25 (n≧4 y≦25), and wherein R 1 or R 2 is a spacer for conjugation to a carrier, with the condition of R 1 =spacer if R 2 =H, or R 2 =spacer if R 1 =H. n The invention also is related with the immunogens containing such oligosaccharide mixtures, with the vaccines containing said immunogens and with the methods to prepare these oligosaccharides as mixtures. Furthermore, the invention includes the use of the vaccines, alone or combined with other vaccines, for the prevention of the infections caused by Haemophilus influenzae type b.
专利号:CZ-2002721-A3 优先权日:1999-08-30 标题 :Mixtures of oligosaccharides, method of their synthesis and synthesis of disaccharide intermediate and disaccharide derivatives, immunogen, vaccine, macromolecule and use of disaccharides and macromolecules
专利号:EP-0565590-B1 优先权日:1990-12-21 标 题:ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) 发明人:KRIVAN HOWARD C; SAMUEL JAMES E; NORBERG NILS THOMAS 权利人:ANTEX BIOLOG INC 摘要:Disclosed herein are immunogenic polysaccharide-H. influenzae adhesin protein conjugates, a purified H. influenzae adhesin protein and related proteins and polypeptides, DNA useful for producing the proteins, synthetic polyribosylribotol phosphate (PRP) oligosaccharides and intermediates useful for their synthesis, and methods of making and using these materials. The conjugates comprise a PRP fragment, preferably a synthetic oligosaccharide, coupled to an H. influenzae adhesin protein. The invention further comprises purified H. influenzae adhesin proteins and novel PRP oligosaccharides. The invention also comprises methods of producing these materials and using them in a vaccine to protect humans and other mammals against H. influenzae infection.
专利号:US-5843463-A 优先权日:1990-12-21 标题:Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae 发明人:KRIVAN HOWARD C; SAMUEL JAMES E 权利人:ANTEXBIOLOGICS INC 摘要:Disclosed herein are immunogenic polysaccharide-H. influenzae adhesin protein conjugates, a purified H. influenzae adhesin protein and related proteins and polypeptides, DNA useful for producing the proteins, synthetic polyribosylribotol phosphate (PRP) oligosaccharides and intermediates useful for their synthesis, and methods of making and using these materials. The conjugates comprise a PRP fragment, preferably a synthetic oligosaccharide, coupled to an H. influenzae adhesin protein. The invention further comprises purified H. influenzae adhesin proteins and novel PRP oligosaccharides. The invention also comprises methods of producing these materials and using them in a vaccine to protect humans and other mammals against H. influenzae infection.
专利号:CN-119613465-A 优先权日:2024-11-11 标 题:Chemical synthesis method of haemophilus influenzae type b capsular polysaccharide derivative
参考标题:Total Synthesis Of Lipoteichoic Acid OfStreptococcus Pneumoniae 作者:Christian Marcus Pedersen,Ignacio Figueroa-Perez,Buko Lindner,Artur J. Ulmer,Ulrich Zähringer,Richard R. Schmidt |发布日期:2010.3.29 摘要:Mixed Signals: The Glycophospholipid 1, Consisting Of Two Cholinylphospho‐galnac Units, Two 2‐acetamino‐4‐amino‐2,4,6‐trideoxygalactose Rings, Three Glucose Residues Each With Different Linkages To Other Sugar Units, And A Ribitolphosphate Residue, Has Been Synthesized. Target 1 Is Recognized By The Immune System, But Not By The Tlr‐2 Signaling Receptor As Previously Postulated.